VisionHealth raises 3 million Euro to finance extended COPD and asthma study for market preparation of Kata®, an innovative digital therapeutic for improved inhalation
PharmiWeb,
DB Speciality Invest, an investment firm of Dr. Dietrich Bruchmann, invests in VisionHealth Funds will be used for EU and U.S.